<DOC>
	<DOC>NCT01311024</DOC>
	<brief_summary>The purpose of this study is to assess the indirect effects of a pneumococcal conjugate vaccine administered to infants on vaccinees' elder non-vaccinated siblings aged 3 to 7 years.</brief_summary>
	<brief_title>Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage</brief_title>
	<detailed_description>The purpose of this study is to assess the indirect effects of a pneumococcal conjugate vaccine administered to infants on vaccinees' elder non-vaccinated siblings aged 3 to 7 years. This study includes a cross-sectional sampling of nasopharyngeal and oropharyngeal swabs in 2011 and a register-based follow-up study for invasive disease, hospital-diagnosed pneumonia, tympanostomy tube surgery and outpatient antimicrobial treatment.</detailed_description>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>age 3 to 7 years younger sibling at least 12 months of age living in the same household participates in the FinIP or 053 trial (regardless of the vaccination schedule) at least one parent with fluent Finnish informed consent from one parent commercial PCV vaccination administered studyrelated PCV vaccination administered (open or blind) history of antimicrobial treatment within 4 weeks (the child can be enrolled later)</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Children</keyword>
	<keyword>Pneumococcal Vaccines</keyword>
</DOC>